News
According to the Associated Press, trial participants received weekly injections of the highest tolerated doses of Zepbound ...
The trial randomized 751 participants across the U.S. and Puerto Rico in a 1:1 ratio to receive maximum tolerated dose of Zepbound (10 mg or 15 mg) or Wegovy (1.7 mg or 2.4 mg). With ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
Tirzepatide (Zepbound) came out on top against semaglutide ... Participants received a maximum tolerated shot of tirzepatide (10 mg or 15 mg) or the maximum tolerated shot of semaglutide (1.7 ...
In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback